Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Neupath Health Inc. ( (TSE:NPTH) ).
NeuPath Health Inc. has appointed Stephen Lemieux as President to drive the next phase of strategic growth, leveraging his financial expertise and experience in healthcare and biopharmaceutical sectors. This move aims to accelerate growth through expanded services, new locations, and acquisitions, enhancing NeuPath’s market position and operational capabilities.
More about Neupath Health Inc.
NeuPath Health Inc. operates a network of healthcare clinics in Ontario and Alberta, focusing on chronic pain treatment, musculoskeletal injuries, sports injuries, and concussions. The company also provides workplace health services, independent medical assessments, and contract research services to pharmaceutical and biotechnology companies.
YTD Price Performance: -18.18%
Average Trading Volume: 84,754
Technical Sentiment Signal: Buy
Current Market Cap: C$9.75M
For detailed information about NPTH stock, go to TipRanks’ Stock Analysis page.